Conclusions Depressive symptoms, often unrecognized, are a major determinant of reduced quality of life in small vessel disease. They account for greater reduction than, and are independent of, disability. This relationship may reflect the proposed causal association between white matter disease and depression. Treatment of depressive symptoms might significantly improve quality of life in small vessel disease.
Introduction
Cerebral small vessel disease (SVD) accounts for 20% of ischemic stroke and is the most common cause of vascular cognitive impairment (1) . Radiologically, it is characterized by discrete lacunar infarcts, with or without diffuse areas of white matter damage (leukoaraiosis). Associated features include cognitive impairment, particularly involving executive function and information processing speed (2, 3) and progressive motor slowing and disability, all factors that might be expected to impact significantly on quality of life (QoL).
Despite its importance, there is little data on QoL in patients presenting with SVD, and the factors that determine any reduction. Where assessments of QoL have been performed in stroke they have been found to be useful indicators of patient recovery and are increasingly being used as outcome measures in research trials. However, QoL studies tend not to differentiate between stroke subtypes that show different levels of impairment both in the acute and chronic phases. Due to the characteristic cognitive profile in patients with SVD, and because concomitant lacunar strokes often result in lesser degrees of disability than larger cortical strokes, there might be different determinants of QoL in this condition. In addition, recent evidence suggests SVD is a risk factor for late onset depression (4) , which itself may also be an important determinant of QoL. A biological mechanism for this has been suggested with depressive symptoms resulting from disruption of complex cortical-sub-cortical circuits. Therefore, depressive symptoms might be hypothesized to be a major factor influencing QoL in SVD. To investigate this, we performed stroke-specific QoL (SS-QoL) (5) assessments in patients presenting with SVD, and at the same time, assessed depression, disability, and cognition.
To identify patients with SVD, we recruited patients with lacunar infarction and no other obvious cause of stroke. Many such individuals also have white matter damage, identified on scanning as white mater hyperintensities, or leukoaraiosis. However, SVD is most common in elderly individuals in whom concomitant brain pathology is frequent. Postmortem studies in patients presenting with presumed vascular dementia, for example, have frequently reported coexistent Alzheimer's pathology. To allow us to replicate our findings in a group with pure SVD and without concomitant age-related pathology, we also studied a group with cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy (CADASIL), a genetic cause of SVD resulting in early onset lacunar stroke and cognitive decline. Radiological appearances are similar to those seen in sporadic SVD with lacunar infarction and leukoaraiosis. Due to the younger age of onset, other concomitant brain pathologies are rare, and for this reason, CADASIL provides a purer model of SVD pathology. To assess the validity of any findings in the groups presenting with sporadic SVD group, we therefore carried out a replication study in a CADASIL cohort.
Methods

Study population 1: sporadic SVD
Consecutive patients presenting with sporadic SVD were identified using the following inclusion criteria: clinical lacunar stroke syndrome (6) and Magnetic Resonance Imaging (MRI) confirmation of lacunar infarction. Subjects were prospectively recruited from specialized stroke services in three district hospitals in South London, UK. In each center, recruitment was from both an acute stroke unit and an outpatient minor stroke/Transient Ischaemic Attack (TIA) service. Exclusion criteria included any cause of stroke other than SVD including any cortical infarct, any large sub-cortical infarcts (>1·5 cm), any cardioembolic source, and extracranial or intracranial large cerebral artery stenosis (>50%). Of patients meeting the inclusion criteria, 75% agreed to participate. The patients were studied at least three-months after their last stroke (mean (standard deviation) 3·7 (5·6) years) to avoid any effects on cognition due to acute ischemia. One hundred subjects were recruited (mean (SD) age 71·1 (8·5) years; 60 men). All patients had brain MRI. The degree of leukoaraiosis on MRI was graded in the SVD group using the semiquantitative Fazekas scale (7), modified to separate degrees of confluent leukoaraiosis:
• Grade 0, no leukoaraiosis • Grade 1, mild leukoaraiosis • Grade 2, moderate confluent leukoaraiosis; and • Grade 3, severe confluent leukoaraiosis (8) .
A control group (n = 55, age 70·6 (7·9) years; 30 men), free of stroke and other central nervous system diseases, were recruited from family doctor practices in the same geographical area and from patients' spouses and friends. Statistical comparisons showed that the control and SVD groups were well-matched for age (P = 0·740) and gender (P = 0·510).
Study population 2: CADASIL
Subjects with a genetically confirmed diagnosis of CADASIL, based on a typical disease-causing cysteine altering mutation in the notch 3 gene, were recruited prospectively from a national CADASIL referral clinic at St George's Hospital, London, UK. Of the patients meeting the inclusion criteria, 78% agreed to participate. Forty subjects were recruited with a mean (SD) age of 51·1 (10·5) years, 15 were male. Of the 40 CADASIL patients, 18 (45%) had previously had a stroke. Seventeen (42·5%) were being treated with antidepressant medication. All had a brain MRI.
A young control group composed of 35 healthy individuals (mean (SD) age 53·0 (8·8) years; 14 men) was also recruited from family doctor practices in South London and from patients' spouses and friends. Recruits from family doctor practice were contacted by letter, and of those contacted, approximately 20% responded, and of the respondents, 85% consented to take part. Statistical comparisons showed that the control and SVD groups were well-matched for age (P = 0·390) and gender (P = 0·824).
A local research ethics committee approved the study and informed; written consent was obtained from all the participants.
Assessment measures
All the patient and control groups were assessed using the same scale to quantify QoL (SS-QoL). The patients were also asked to complete Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) scales, and disability (modified Rankin scale (mRS)) measures. Depression was assessed in the (older) sporadic SVD group using the ageappropriate Geriatric Depression Scale (GDS), and in the (younger) CADASIL cases using the Montgomery-Åsberg Depression Rating Scale (MADRS). All measures were administered by experienced neurologists or psychologists with full medical and medication histories taken; where patients could not recall their medications, prescription lists or hospital records were obtained.
SS-QoL (5)
This scale was developed as a QoL measure for use in stroke trials. It provides different domains of QoL and has established internal reliability and sensitivity to change (5) . Due to the chronic nature of SVD, and because the SS-QoL had been developed for a single postacute stroke assessment, the scale items were modified into the present tense to reflect general current experiences (e.g. 'I often have to stop and rest during the day'). The scores were collapsed into aggregate scores for each domain, where a high score indicates better QoL.
GDS-30 (9)
Depressive symptoms in the SVD group were assessed by the 30-item GDS. This is a self-report measure, which includes 30 items with yes/no responses, for example,'do you feel that your life is empty?' and 'are you in good spirits most of the time?'
MADRS (10)
Depressive symptoms in the CADASIL group were assessed using the MADRS, a clinician-administered scale with 10 questions relating to depressive symptoms. Responses range from 0-6 points dependent on the severity of the symptom.
ADL (11)
ADLs were measured using Barthel's index. The scale assesses the level of basic function and independent living.
IADL [see (12)]
The IADL scale measures higher level everyday function related to independent living, such as the ability to manage finances or use public transportation.
mRS (13)
Functional status was measured using the mRS, a six-point rating scale developed to measure disability following stroke.
Mini-Mental State Exam (MMSE) (14)
General cognition was measured using the MMSE. A widely used test of dementia, the scale is composed of a 30-point evaluation of the patient's cognitive function, incorporating memory, concentration, copying, object recognition, and time/place orientation tasks.
Data completeness
In the SVD group SSQoL data were available for all cases and all controls. Additional tests were completed by 98 of the 100 SVD cases, but GDS-30 scores were not available in a further nine of these, and ADL was not available for one further patient. In the CADASIL study, SSQoL data was available for all cases and all controls; all CADSIL patients completed additional measures.
Statistical analysis
QoL outcomes in SVD compared with a normal population Independent t-tests were used to compare differences between each patient group and their respective controls on total QoL scores and for the QoL sub-scales. The total QoL score was calculated pro rata to account for intermittent missing responses (no. sub-tests ¥ mean sub-tests). Effect sizes (Glass's D) were calculated as (control group mean -patient mean) / (control SD). Scale reliability score for each group and the total sample were calculated using Cronbach's alpha.
Predictors of QoL outcomes in SVD
Stepwise regressions were performed to examine the relative contributions of disability, depression, and ADL to QoL in SVD and CADASIL. Absolute relationships between the SSQoL and measures of disability, depression, and cognition, as well as leukoaraiosis grade, were assessed using Pearson's correlation coefficients. The same analysis was also repeated with the mood sub-scale removed from the SSQoL, based on the notion that the SSQoL is sensitive to mood state (15) , and this might result in inflated associations between depression and QoL due to the same thing being measured in each case.
Predictor independence
To examine whether the relationship between depression and QoL was mediated by disability, the interaction between depression and disability was calculated using moderation (16) and mediation analyses.
Model replication
To test the reliability of the regression model, the predicted QoL scores were calculated for all participants first using the regression equation derived from the sporadic cases and then using the regression equation derived from the genetic cases. This was correlated to give a measure of model stability.
Results
Demographics of the patient and control groups are shown in Table 1 .
Study 1: sporadic SVD cohort
The mean (SD) total SSQoL score was significantly lower for sporadic SVD patients than for controls, 196·8 (35·2) vs. 226·8 (15·3), P < 0·0001. This reduction was seen across all subdomains of the SSQoL scale ( Table 2 ). The modified SSQoL showed high internal consistency for controls (a = 0·91), SVD patients (a = 0·96), and for all participants combined (a = 0·97). Of the SVD patients, 34% fitted the GDS criteria for depression (9) , and around half of those who fell in the normal range reported five or more depressive symptoms.
Predictors of QoL in SVD
There were significant correlations between all of the different assessment measures and SSQoL [GDS r = -0·748, P < 0·0001 (Fig. 1) ; mRS r = -0·567, P < 0·0001; ADL r = 0·449, 
Values are number (%) or mean (SD) as appropriate. *Significantly different from control group, P < 0·0001. SS-QoL, Stroke-Specific Quality of Life; GDS-30, Geriatric Depression Scale; MADRS, Montgomery-Åsberg Depression Rating Scale; ADL, Activities of Daily Living; IADL, Instrumental Activities of Daily Living; MMSE, Mini-Mental State Exam; SVD, small vessel disease; CADASIL, cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy. 
Total scores and scores for each individual domain are given. D = Glass' effect size. SVD, small vessel disease; CADASIL, cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy.
P < 0·00001; IADL r = 0·453, P < 0·0001; MMSE r = 0·235, P < 0·021]. To determine which of these factors best predicted QoL in SVD, a stepwise multiple regression was carried out entering IADL, ADL, mRS, MMSE, and GDS-30 into the model. The final model accounted for 71·3% of the total variance in SSQoL, with GDS-30 accounting for the highest proportion (52·9%), and mRS accounting for the remaining 18·4% (Table 3) . When mood-related items (5/49) were excluded in calculating the overall QoL score, the model remained significant, accounting for 70·8% of the variance with depression accounting for the highest proportion (47%).
Independence of predictor variables
Moderated regressions for the effect of disability on the depression/QoL relationship showed that the interaction term (mRScGDS-30c) did not correlate with QoL (r = -0·041, P = 0·352) and the regression model remained unchanged (R 2 = 0·713, P < 0·0001) when mRScGDS-30c was included in the model. Additional partial correlations confirmed that the relationship between GDS-30 and SSQoL was not mediated by mRS scores (r = -0·763, P < 0·0001). Similarly, the relationship between mRS score and QoL was not mediated by GDS-30 (r = -0·636, P < 0·0001).
Age as a covariate
Age and QoL did not correlate significantly (r = -0·108, P = 0·289). Further partial correlations confirmed that including age as a covariate had no effect on the relationship between QoL and mRS score (r = -0·592, P < 0·0001) or QoL and GDS-30 (r = 0·739, P < 0·0001). 
Leukoaraiosis grade and QoL
Leukoraiosis grade correlated significantly with SSQoL (r = -0·283, P = 0·006), mRS (r = 0·241, P = 0·018), ADL (r = -0·216, P = 0·037), and GDS-30 (r = 0·208, P = 0·05) but did not correlate with IADL (r = -0·177, P = 0·087) or MMSE (r = -0·012, P = 0·911).
Study 2: CADASIL cohort
The mean (SD) total SSQoL score was significantly lower for CADASIL patients than for controls (202·0 (29·7) vs. 228·6 (13·1), P < 0·0001). Analyses across sub-scales also revealed significant (P < 0·05) deficits in energy, language, mobility, mood, personality, self-care, social roles, upper extremity function, family life, thinking, and work, but not for vision ( Table 2 ). The modified SSQoL showed high internal validity when used with controls (a = 0·87), CADASIL patients (a = 0·96), and for all participants combined (a = 0·95). Of the CADASIL patients, 40% met the MADRS criteria for mild or moderate depression (17) .
Predictors of QoL in CADASIL
MADRS, IADL, mRS, and MMSE correlated significantly with overall QoL [MADRS r = -0·649, P < 0·0001 (Fig. 2) ; mRS r = -0·515, P = 0·001; IADL r = -0·392, P = 0·012; MMSE r = 0·434; P = 0·005]. The correlation with ADL approached significance (r = 0·311, P = 0·051). A stepwise multiple regression was carried out to determine the best predictors of QoL in CADASIL. The predictor variables entered into the model were IADL, ADL, mRS, MMSE, and MADRS. The final model accounted for 59·7% of the variance in SSQOL, with depressive symptoms accounting for the majority of this (42·2%), and the remaining variance accounted for by mRS score (Table 3 for the model summary). When mood-related items were excluded from the total SSQoL, the model remained significant, accounting for 58·5% of the variance with depression accounting for the highest proportion (36·6%).
Moderation and mediation analyses
The interaction term between the MADRS and Rankin scores (mRScMADRSc) did not correlate with QoL (r = -0·003, P = 0·984), and the regression model remained unchanged (R 2 = 0·597, P < 0·0001) when mRScMADRSc was included in the model. Additional partial correlations confirmed that the relationship between MADRS scores and SSQoL was not mediated by mRS scores (r = -0·673, P < 0·0001). Similarly, the relationship between mRS scores and QoL was not mediated by MADRS scores (r = -0·551, P < 0·0001).
Age as a covariate
The results showed that the relationships between QoL and mRS score (r = -0·425, P < 0·004) and QoL and MADRS (r = -0·629, P < 0·0001) remained significant when age was held as a covariate.
Leukoaraiosis grade and QoL
Leukoraiosis grade correlated significantly with MMSE (r = -0·320, P = 0·044) but did not correlate significantly with SSQoL (r = -0·277, P = 0·084), mRS (r = 0·298, P = 0·086), IADL (r = -0·275, P = 0·062) or MADRS (r = -0·253, P = 0·115), or ADL (r = -0·277, P = 0·084).
Model replication
The regression model for the SVD group showed a striking similarity to the model for the younger CADASIL group. Cross-validation revealed that the predictions from the two independently calculated models were highly correlated (r = 0·972, P < 0·0001 and r = 0·977, P < 0·0001), indicating model stability (Table 4) .
Post hoc analysis
As MMSE did not remain in the stepwise regression model, correlations with the depression indices were calculated for both groups in order to examine whether the depression scores were a consequence of reduced cognition. The results showed that depression and MMSE score did not significantly correlate for either group (SVD r = -0·079; P = 0·468; CADASIL r = -0·289; P = 0·071).
Discussion
This study shows that in patients with both sporadic SVD, and younger onset SVD due to CADASIL, depressive symptoms are a major predictor of the reduced QoL. They are a more important predictor than disability and act independently of disability.
In both patient groups, depressive symptoms accounted for approximately half of the variance in QoL. The strikingly similar findings in the sporadic SVD and CADASIL groups suggest that this association is a consistent feature of SVD. The QoL measure we used does include some indicators sensitive to mood; however, excluding these from the analysis did not significantly alter the results. The only other variable which remained significantly associated with QoL was disability, assessed by the mRS, but this accounted for a lesser degree of variance in QoL. Depression and disability were found to predict QoL independently of one another.
Many recent studies have associated white matter ischemia with late-onset depression (4, 18) , and depression has been found to be a prominent feature of CADASIL, where it frequently presents before clinical symptoms such as stroke (19) . This has led to the hypothesis that white matter ischemia and subsequent white matter tract damage results in disruption of cortical-sub-cortical connections underlying complex networks involved in the regulation of mood (20, 21) . MRI was performed in all patients allowing us to grade the degree of leukoaraiois and determine whether it also related to QoL. In the sporadic SVD group, leukoaraiosis grade was positively related to QoL. We also confirmed a graded relationship between increasing degree of leukoaraiosis and depression and disability. This is consistent with previous work showing that increased leukoaraiosis is an important predictor of older-onset depression and disability (22) . In the CADASIL group, we found a significant correlation between leukoaraiosis grade and MMSE but no significant correlations between other functional measures and leukoaraiosis grade, although the absolute r-values were similar to those seen in the sporadic SVD group. The lack of association may partly reflect the smaller sample size. Of note, the finding of similar associations in the CADASIL group relating to depression and QoL enhances the importance of vascular factors in the pathogenesis of the dysexecutive-depressive syndrome of SVD, underlining the usefulness of comparing these two groups of patients, with CADASIL not complicated by neurodegenerative changes associated with old age.
A limitation of this study is that the scope of our observations is confined to the domains examined. For example, apathy and motivation are features not investigated in the current study, and other groups have reported an association between apathy and QoL in CADASIL (23) . Additionally, it could be argued that mood state, including levels of depression, contributes to QoL, and for this reason, QoL scales may include mood-related items. To explore this, we removed depression items from the QoL analysis and obtained similar results. Nevertheless, there remains the issue that lower mood might result in people reporting experiencing a low QoL, while this may not necessarily by the case. Similarly, measurement of ADL was based on self-report and this might be influenced by mood state or lack of awareness of disability by the patient. To address this issue, informant-based measurement of these aspects could be used, although it should be recognized that psychosocial factors have also been found to impact on informant ratings in this regard (24) . Our results have a number of clinical implications. First, not surprisingly, they highlight that SVD is associated with a markedly reduced QoL. Interestingly, they demonstrate the importance of depressive symptoms in the reduction. This may reflect the suggested causal biological associations between white matter disease and depression. Importantly, we also discovered depression was not often clinically recognized or treated in the sporadic SVD group: only 4% of patients were receiving antidepressant medication at the time of the study, although 34% met the criteria for depression on the GDS. It is possible that more intensive treatment may result in significant improvements, not only in mood, but also in QoL in this patient group. Further work is therefore required to assess the causal relationship through investigation of the impact of treating depression, which is often undiagnosed in this patient group.
